Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.598. It has been cited 53 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.598
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging
Grant: P50-AG05142
National Institutes of Health
Grant: 2P50AG005142-31
Metabolic Factors in AD
Influential Citations
2
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 1 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 2 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 2 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 3 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 3 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 4 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease
Additional file 4 of Disturbed circadian rhythm and retinal degeneration in a mouse model of Alzheimer’s disease